Evidence review · Published July 22, 2026 · Sources checked July 22, 2026
GHK-Cu research overview
GHK-Cu is the copper(II) complex of the tripeptide glycyl-L-histidyl-L-lysine.
Evidence boundary: published research does not establish the identity or performance of a separately supplied batch. The catalog product is supplied only for qualified in vitro laboratory research and is not for human or animal use.
What is GHK-Cu?
Animal wound-chamber and skin-wound studies have measured collagen, glycosaminoglycans, gene expression, fibroblast behavior, and tissue organization.
- Research category
- Tissue & cellular signaling
- Study models represented
- Rat and guinea-pig wound models; cultured fibroblasts
- Names in the literature
- Copper tripeptide-1; Gly-His-Lys-Cu
- Primary boundary
- Animal wound and cell-culture outcomes do not directly predict effects in people.
What does the selected evidence support?
These model-specific results do not establish a clinical outcome, cosmetic claim, or batch identity for separately supplied material.
Primary sources
- Maquart et al., Journal of Clinical Investigation (1993) — Rat wound-chamber study measuring extracellular-matrix accumulation. DOI: 10.1172/JCI116842
- Siméon et al., Journal of Investigative Dermatology (1996) — Guinea-pig skin-wound and cultured-fibroblast experiments. DOI: 10.1111/1523-1747.ep12336260
Research literature and product documentation are different
A publication describes a study and its results. A batch-specific Certificate of Analysis documents characteristics of a supplied research material. One does not substitute for the other.
Review GHK-Cu product specifications · Browse the COA library · Read the research-use policy
Prepared by The Pep Labs Research Editorial Team. This evidence summary is not medical advice and contains no dosing or administration guidance.